nhboy
Ubi bene ibi patria
" Newly-released financial disclosure documents show that Dr. Scott Gottlieb, President Trump’s nominee to the lead the Food and Drug Administration, has received significant payments from the opioid industry — while attacking attempts to deter the explosion of opioid pill mills.
The FDA has some of the most significant authority in the federal government to oversee manufacturers of prescription painkillers. Gottlieb is set to appear for his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee at 10 a.m. tomorrow.
Gottlieb’s disclosure statements, required under federal law, show that since the beginning of 2016 he has received almost $45,000 in speaking fees from firms involved in the manufacture and distribution of opioids.
“Our country is in desperate need of an FDA commissioner who will take on the opioid lobby, not one who has a track record of working for it,” said Dr. Andrew Kolodny, the Co-Director of Opioid Policy Research at Brandeis University, reacting to this information. "
More here: https://theintercept.com/2017/04/04/scott-gottlieb-opioid/
The FDA has some of the most significant authority in the federal government to oversee manufacturers of prescription painkillers. Gottlieb is set to appear for his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee at 10 a.m. tomorrow.
Gottlieb’s disclosure statements, required under federal law, show that since the beginning of 2016 he has received almost $45,000 in speaking fees from firms involved in the manufacture and distribution of opioids.
“Our country is in desperate need of an FDA commissioner who will take on the opioid lobby, not one who has a track record of working for it,” said Dr. Andrew Kolodny, the Co-Director of Opioid Policy Research at Brandeis University, reacting to this information. "
More here: https://theintercept.com/2017/04/04/scott-gottlieb-opioid/
